nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—Injection site haematoma—Octreotide—thymus cancer	0.107	0.164	CcSEcCtD
Azacitidine—Abdominal tenderness—Octreotide—thymus cancer	0.04	0.0614	CcSEcCtD
Azacitidine—DNMT3A—hematopoietic system—thymus cancer	0.0305	0.09	CbGeAlD
Azacitidine—CDA—hematopoietic system—thymus cancer	0.0289	0.085	CbGeAlD
Azacitidine—DNMT3A—pituitary gland—thymus cancer	0.0227	0.0667	CbGeAlD
Azacitidine—DNMT3A—lymphoid tissue—thymus cancer	0.0215	0.0633	CbGeAlD
Azacitidine—CDA—lymphoid tissue—thymus cancer	0.0203	0.0599	CbGeAlD
Azacitidine—DNMT3A—thyroid gland—thymus cancer	0.0195	0.0575	CbGeAlD
Azacitidine—CDA—bone marrow—thymus cancer	0.0185	0.0545	CbGeAlD
Azacitidine—DNMT1—hematopoietic system—thymus cancer	0.0185	0.0544	CbGeAlD
Azacitidine—CDA—thyroid gland—thymus cancer	0.0185	0.0544	CbGeAlD
Azacitidine—Loose stools—Octreotide—thymus cancer	0.0183	0.028	CcSEcCtD
Azacitidine—DNMT3A—lung—thymus cancer	0.0177	0.0522	CbGeAlD
Azacitidine—Cholecystitis—Octreotide—thymus cancer	0.0176	0.027	CcSEcCtD
Azacitidine—Haemorrhoids—Octreotide—thymus cancer	0.0172	0.0264	CcSEcCtD
Azacitidine—DNMT1—epithelium—thymus cancer	0.0169	0.0497	CbGeAlD
Azacitidine—Haematoma—Octreotide—thymus cancer	0.0161	0.0247	CcSEcCtD
Azacitidine—DNMT1—cardiac atrium—thymus cancer	0.014	0.0413	CbGeAlD
Azacitidine—DNMT1—pituitary gland—thymus cancer	0.0137	0.0404	CbGeAlD
Azacitidine—DNMT1—lymphoid tissue—thymus cancer	0.013	0.0383	CbGeAlD
Azacitidine—Injection site pain—Octreotide—thymus cancer	0.0124	0.019	CcSEcCtD
Azacitidine—Petechiae—Octreotide—thymus cancer	0.0123	0.0188	CcSEcCtD
Azacitidine—DNMT3A—lymph node—thymus cancer	0.0121	0.0357	CbGeAlD
Azacitidine—DNMT1—bone marrow—thymus cancer	0.0118	0.0349	CbGeAlD
Azacitidine—DNMT1—thyroid gland—thymus cancer	0.0118	0.0348	CbGeAlD
Azacitidine—Contusion—Octreotide—thymus cancer	0.0116	0.0178	CcSEcCtD
Azacitidine—CDA—lymph node—thymus cancer	0.0115	0.0338	CbGeAlD
Azacitidine—Cellulitis—Octreotide—thymus cancer	0.0111	0.0171	CcSEcCtD
Azacitidine—Herpes simplex—Octreotide—thymus cancer	0.011	0.0168	CcSEcCtD
Azacitidine—DNMT1—lung—thymus cancer	0.0107	0.0316	CbGeAlD
Azacitidine—Injection site reaction—Octreotide—thymus cancer	0.0101	0.0154	CcSEcCtD
Azacitidine—Wheezing—Octreotide—thymus cancer	0.00982	0.0151	CcSEcCtD
Azacitidine—Cardiac failure congestive—Octreotide—thymus cancer	0.0081	0.0124	CcSEcCtD
Azacitidine—Nasal congestion—Octreotide—thymus cancer	0.00806	0.0124	CcSEcCtD
Azacitidine—Adenosine triphosphate—AKT1—thymus cancer	0.00802	1	CrCbGaD
Azacitidine—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00734	0.0113	CcSEcCtD
Azacitidine—Pain in extremity—Octreotide—thymus cancer	0.00734	0.0113	CcSEcCtD
Azacitidine—DNMT1—lymph node—thymus cancer	0.00734	0.0216	CbGeAlD
Azacitidine—Dehydration—Octreotide—thymus cancer	0.00683	0.0105	CcSEcCtD
Azacitidine—Dry skin—Octreotide—thymus cancer	0.00673	0.0103	CcSEcCtD
Azacitidine—Abdominal pain upper—Octreotide—thymus cancer	0.00671	0.0103	CcSEcCtD
Azacitidine—Cramp muscle—Octreotide—thymus cancer	0.00661	0.0101	CcSEcCtD
Azacitidine—Nasopharyngitis—Octreotide—thymus cancer	0.00657	0.0101	CcSEcCtD
Azacitidine—Muscular weakness—Octreotide—thymus cancer	0.00648	0.00993	CcSEcCtD
Azacitidine—Abdominal distension—Octreotide—thymus cancer	0.00639	0.00979	CcSEcCtD
Azacitidine—Sweating increased—Octreotide—thymus cancer	0.00618	0.00948	CcSEcCtD
Azacitidine—Bronchitis—Octreotide—thymus cancer	0.0061	0.00936	CcSEcCtD
Azacitidine—Dysuria—Octreotide—thymus cancer	0.00593	0.0091	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Octreotide—thymus cancer	0.0059	0.00904	CcSEcCtD
Azacitidine—Weight decreased—Octreotide—thymus cancer	0.00574	0.0088	CcSEcCtD
Azacitidine—Pneumonia—Octreotide—thymus cancer	0.00569	0.00872	CcSEcCtD
Azacitidine—Depression—Octreotide—thymus cancer	0.00564	0.00865	CcSEcCtD
Azacitidine—Urinary tract infection—Octreotide—thymus cancer	0.0055	0.00843	CcSEcCtD
Azacitidine—Haematuria—Octreotide—thymus cancer	0.0054	0.00827	CcSEcCtD
Azacitidine—Hepatobiliary disease—Octreotide—thymus cancer	0.00535	0.0082	CcSEcCtD
Azacitidine—Epistaxis—Octreotide—thymus cancer	0.00534	0.00818	CcSEcCtD
Azacitidine—Sinusitis—Octreotide—thymus cancer	0.00531	0.00814	CcSEcCtD
Azacitidine—Rhinitis—Octreotide—thymus cancer	0.00509	0.00781	CcSEcCtD
Azacitidine—Hypoaesthesia—Octreotide—thymus cancer	0.00505	0.00775	CcSEcCtD
Azacitidine—Pharyngitis—Octreotide—thymus cancer	0.00504	0.00773	CcSEcCtD
Azacitidine—Oedema peripheral—Octreotide—thymus cancer	0.005	0.00767	CcSEcCtD
Azacitidine—Cardiac disorder—Octreotide—thymus cancer	0.00471	0.00723	CcSEcCtD
Azacitidine—Immune system disorder—Octreotide—thymus cancer	0.00459	0.00703	CcSEcCtD
Azacitidine—Alopecia—Octreotide—thymus cancer	0.00449	0.00688	CcSEcCtD
Azacitidine—Mental disorder—Octreotide—thymus cancer	0.00445	0.00682	CcSEcCtD
Azacitidine—Malnutrition—Octreotide—thymus cancer	0.00442	0.00678	CcSEcCtD
Azacitidine—Erythema—Octreotide—thymus cancer	0.00442	0.00678	CcSEcCtD
Azacitidine—Back pain—Octreotide—thymus cancer	0.00428	0.00656	CcSEcCtD
Azacitidine—Muscle spasms—Octreotide—thymus cancer	0.00425	0.00652	CcSEcCtD
Azacitidine—Ill-defined disorder—Octreotide—thymus cancer	0.0041	0.00629	CcSEcCtD
Azacitidine—Anaemia—Octreotide—thymus cancer	0.00409	0.00627	CcSEcCtD
Azacitidine—Malaise—Octreotide—thymus cancer	0.00399	0.00611	CcSEcCtD
Azacitidine—Syncope—Octreotide—thymus cancer	0.00397	0.00608	CcSEcCtD
Azacitidine—Loss of consciousness—Octreotide—thymus cancer	0.00389	0.00596	CcSEcCtD
Azacitidine—Cough—Octreotide—thymus cancer	0.00386	0.00592	CcSEcCtD
Azacitidine—Convulsion—Octreotide—thymus cancer	0.00383	0.00587	CcSEcCtD
Azacitidine—Hypertension—Octreotide—thymus cancer	0.00382	0.00585	CcSEcCtD
Azacitidine—Chest pain—Octreotide—thymus cancer	0.00376	0.00577	CcSEcCtD
Azacitidine—Arthralgia—Octreotide—thymus cancer	0.00376	0.00577	CcSEcCtD
Azacitidine—Myalgia—Octreotide—thymus cancer	0.00376	0.00577	CcSEcCtD
Azacitidine—Anxiety—Octreotide—thymus cancer	0.00375	0.00575	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00374	0.00573	CcSEcCtD
Azacitidine—Discomfort—Octreotide—thymus cancer	0.00372	0.0057	CcSEcCtD
Azacitidine—Anaphylactic shock—Octreotide—thymus cancer	0.00361	0.00553	CcSEcCtD
Azacitidine—Oedema—Octreotide—thymus cancer	0.00361	0.00553	CcSEcCtD
Azacitidine—Infection—Octreotide—thymus cancer	0.00359	0.0055	CcSEcCtD
Azacitidine—Shock—Octreotide—thymus cancer	0.00355	0.00544	CcSEcCtD
Azacitidine—Nervous system disorder—Octreotide—thymus cancer	0.00354	0.00543	CcSEcCtD
Azacitidine—Thrombocytopenia—Octreotide—thymus cancer	0.00353	0.00542	CcSEcCtD
Azacitidine—Tachycardia—Octreotide—thymus cancer	0.00352	0.0054	CcSEcCtD
Azacitidine—Skin disorder—Octreotide—thymus cancer	0.00351	0.00537	CcSEcCtD
Azacitidine—Hyperhidrosis—Octreotide—thymus cancer	0.00349	0.00535	CcSEcCtD
Azacitidine—Anorexia—Octreotide—thymus cancer	0.00344	0.00527	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00329	0.00504	CcSEcCtD
Azacitidine—Insomnia—Octreotide—thymus cancer	0.00326	0.005	CcSEcCtD
Azacitidine—Dyspnoea—Octreotide—thymus cancer	0.00322	0.00493	CcSEcCtD
Azacitidine—Dyspepsia—Octreotide—thymus cancer	0.00318	0.00487	CcSEcCtD
Azacitidine—Decreased appetite—Octreotide—thymus cancer	0.00314	0.00481	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00312	0.00478	CcSEcCtD
Azacitidine—Fatigue—Octreotide—thymus cancer	0.00311	0.00477	CcSEcCtD
Azacitidine—Pain—Octreotide—thymus cancer	0.00309	0.00473	CcSEcCtD
Azacitidine—Constipation—Octreotide—thymus cancer	0.00309	0.00473	CcSEcCtD
Azacitidine—Feeling abnormal—Octreotide—thymus cancer	0.00297	0.00456	CcSEcCtD
Azacitidine—Gastrointestinal pain—Octreotide—thymus cancer	0.00295	0.00452	CcSEcCtD
Azacitidine—Urticaria—Octreotide—thymus cancer	0.00287	0.00439	CcSEcCtD
Azacitidine—Abdominal pain—Octreotide—thymus cancer	0.00285	0.00437	CcSEcCtD
Azacitidine—Body temperature increased—Octreotide—thymus cancer	0.00285	0.00437	CcSEcCtD
Azacitidine—Hypersensitivity—Octreotide—thymus cancer	0.00266	0.00408	CcSEcCtD
Azacitidine—Asthenia—Octreotide—thymus cancer	0.00259	0.00397	CcSEcCtD
Azacitidine—Pruritus—Octreotide—thymus cancer	0.00255	0.00391	CcSEcCtD
Azacitidine—Diarrhoea—Octreotide—thymus cancer	0.00247	0.00379	CcSEcCtD
Azacitidine—Dizziness—Octreotide—thymus cancer	0.00239	0.00366	CcSEcCtD
Azacitidine—Vomiting—Octreotide—thymus cancer	0.00229	0.00352	CcSEcCtD
Azacitidine—Rash—Octreotide—thymus cancer	0.00228	0.00349	CcSEcCtD
Azacitidine—Dermatitis—Octreotide—thymus cancer	0.00227	0.00348	CcSEcCtD
Azacitidine—Headache—Octreotide—thymus cancer	0.00226	0.00347	CcSEcCtD
Azacitidine—Nausea—Octreotide—thymus cancer	0.00214	0.00329	CcSEcCtD
